Adolescent Weight Management Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00212173|
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : April 17, 2015
Protocol #1:The goals of this study was to examine whether increased weight loss in obese adolescent is induced when the weight loss medication sibutramine is added to a family-based, behavioral weight control program.
Protocol #2: This study aims to improve the behavioral treatment of obesity during adolescence. A behavioral program using regular foods will be compared to a behavioral program using a structured meal plan (a portion-controlled approach with liquid-meal replacements [nutritional supplements]). This structured approach may be better for the promotion of weight loss compared to a diet of regular foods.
|Condition or disease||Intervention/treatment||Phase|
|Protocol #1:Behavioral Therapy + Placebo or Sibutramine Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food||Drug: Sibutramine Dietary Supplement: Slim Fast||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||120 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Behavioral & Pharmacologic Therapy of Adolescent Obesity|
|Actual Study Completion Date :||August 2007|
- Blood Pressure
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00212173
|Principal Investigator:||Robert I Berkowitz, MD||Children's Hospital of Philadelphia|